Journal
BIOMOLECULES
Volume 9, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/biom9070270
Keywords
diarylpentanoid; curcumin; anticancer activity; molecular pathway; cancer
Categories
Funding
- Fundamental Research Grant Scheme [FRGS/1/2013/SKK01/MUSM/02/1]
- Ministry of Higher Education, Malaysia
Ask authors/readers for more resources
While curcumin has a range of therapeutic benefits, its potent anticancer activity remains an attractive avenue for anticancer research owing to the multifactorial nature of cancer itself. The structure of curcumin has thus been used as a lead to design more potent analogues, and diarylpentanoids in particular have shown improved cytotoxicity over curcumin. Investigations of diarylpentanoids have demonstrated that these compounds exert anti-cancer effects through several signalling pathways that are associated with cancer. This review focuses on selected diarylpentanoids and highlights molecular targets that modulate key pathways involved in cancer such as NF-kappa B, MAPK/ERK, and STAT signalling. Future research will need to focus on drug interactions to explore potential synergistic actions of diarylpentanoids and further establish the use of diverse animal models.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available